Proteomics of RNA polymerase interactomes in pathogenic bacteria
病原菌 RNA 聚合酶相互作用组的蛋白质组学
基本信息
- 批准号:8339433
- 负责人:
- 金额:$ 21.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-09-28 至 2014-08-31
- 项目状态:已结题
- 来源:
- 关键词:AffinityAffinity ChromatographyAnthrax diseaseArchitectureBacillus anthracisBinding ProteinsBiochemicalBiological AssayCellsChemicalsClassificationCodeComplexDNA-Directed RNA PolymeraseDataDockingDrug Delivery SystemsDrug DesignElastinEngineeringEnzyme GeneEnzymesFormaldehydeFutureGene ExpressionGene Expression RegulationGenesGeneticGenetic TranscriptionGenomeGenomicsGrowthHomology ModelingIn VitroMacromolecular ComplexesMapsMass Spectrum AnalysisMeasuresMethodsModelingMolecularOrganismOrphanPathway interactionsPeptidesPhosphoric Monoester HydrolasesPhosphotransferasesPositioning AttributePrecipitationProtein KinaseProteinsProteomicsRegulationResearchSeriesSet proteinStaphylococcus aureusStructural ModelsStructureSurveysTechniquesTimeToxinVirulenceVirulence FactorsWorkbasecomputerized data processingcomputerized toolscostcrosslinkhis6 tagin vivoinsightinterestleucylmethioninemacromolecular assemblynoveloperationpathogenpathogenic bacteriaresearch studytranscription factor
项目摘要
DESCRIPTION (provided by applicant): This proposal combines mass-spectrometric, genetic, and computational approaches to illuminate the transient interactions of the central enzyme of gene expression, RNA polymerase, in pathogenic bacteria Staphylococcus aureus and Bacillus anthracis, as well as the topology and composition of the more stable macromolecular complexes formed by this enzyme in vivo. A handful of virulence regulators have been identified in these organisms, but their mechanisms, co-factors, modifying enzymes (such as kinases or phosphatases) remain largely obscure. In addition, the genomes of these pathogens encode hundreds of "orphan" regulators, annotated as hypothetical transcription factors based on homology to known factors from other organisms, and a number of proteins with no predicted function. In a series of pilot experiments we have identified among RNA polymerase-binding proteins a major anthrax virulence factor, AtxA, a S. aureus Tex(for toxin expression)-like factor YhgF, and several proteins of unknown function. We propose to expand this work to carry out a comprehensive characterization of RNA polymerase-interacting factors (interactome), to identify potential virulence regulators and their co-factors and modifying enzymes, and to elucidate the composition and topology of their complexes in vivo. We will use strains of B. anthracis and S. aureus, engineered to express genomic copies of the genes, coding for affinity-tagged subunits of RNA polymerase and transcription factors of interest, to isolate their native complexes and characterize their composition by mass-spectrometry. We will explore a variety of growth conditions, including those where virulence factors expression is induced, and employ various techniques to trap and enrich for transient interactions. As a result we will have obtained a comprehensive survey of RNA polymerase interactome, and interactomes of the key transcription regulators, identifying new transcription factors and providing insights into the mechanisms of the known ones. By performing in vivo cross-linking and isolating affinity tagged complexes as described above, we will obtain covalently stabilized "snap-shots" of RNA polymerase complexes with accessory factors. Intermolecular cross-links will be "mapped" (position of the cross-link and identity of cross-linked peptides will be determined) using previously enumerated interactomes as the search space (reducing the computational cost and time). Whenever possible we will use available structural information and build homology models of the factors to generate structural models (via molecular docking approaches such as HADDOCK) of the complexes by applying spacial constrains obtained from the "mapping" data. Otherwise we will process these data to elucidate composition and topology of the complexes which structures are not available and can not be modeled with high confidence. Taken together this research will advance our understanding of gene expression in B. anthracis and S. aureus, including that of virulence factors, facilitate creation of the in vitro transcription assays for these pathogens, aid the discovery of new transcription factors, their co-factors and regulators of activity, provide mechanistic and structural insights into the operation of known virulence regulators, and identification of novel ones.
描述(由申请人提供):该提案结合了质谱、遗传和计算方法,以阐明致病菌金黄色葡萄球菌和炭疽杆菌中基因表达的中心酶 RNA 聚合酶的瞬时相互作用,以及拓扑和结构。由该酶在体内形成的更稳定的大分子复合物的组成。在这些生物体中已经鉴定出少数毒力调节因子,但它们的机制、辅助因子、修饰酶(例如激酶或磷酸酶)仍然很大程度上不清楚。此外,这些病原体的基因组编码数百个“孤儿”调节因子,根据与其他生物体已知因子的同源性,被注释为假设的转录因子,以及许多没有预测功能的蛋白质。在一系列初步实验中,我们在 RNA 聚合酶结合蛋白中鉴定出了主要的炭疽毒力因子 AtxA、金黄色葡萄球菌 Tex(用于毒素表达)样因子 YhgF 和几种功能未知的蛋白质。我们建议扩大这项工作,对RNA聚合酶相互作用因子(相互作用组)进行全面表征,识别潜在的毒力调节因子及其辅助因子和修饰酶,并阐明其体内复合物的组成和拓扑结构。 我们将使用炭疽芽孢杆菌和金黄色葡萄球菌菌株,这些菌株经过改造可表达基因的基因组拷贝,编码亲和标记的 RNA 聚合酶亚基和感兴趣的转录因子,分离它们的天然复合物并通过质谱分析表征它们的组成。我们将探索各种生长条件,包括诱导毒力因子表达的条件,并采用各种技术来捕获和富集瞬时相互作用。因此,我们将获得对 RNA 聚合酶相互作用组和关键转录调节因子相互作用组的全面调查,识别新的转录因子并提供对已知转录因子机制的见解。 通过如上所述进行体内交联和分离亲和标记复合物,我们将获得具有辅助因子的RNA聚合酶复合物的共价稳定“快照”。使用先前列举的相互作用组作为搜索空间(减少计算成本和时间),将“映射”分子间交联(将确定交联的位置和交联肽的身份)。只要有可能,我们将使用可用的结构信息并构建因子的同源模型,通过应用从“映射”数据获得的空间约束来生成复合物的结构模型(通过分子对接方法,例如 HADDOCK)。否则,我们将处理这些数据以阐明复合物的组成和拓扑结构,这些结构不可用且无法高置信度地建模。 总而言之,这项研究将增进我们对炭疽芽孢杆菌和金黄色葡萄球菌基因表达的理解,包括毒力因子的基因表达,促进这些病原体的体外转录测定的创建,帮助发现新的转录因子及其辅助因子和活性调节因子,为已知毒力调节因子的运作提供机制和结构见解,并识别新的毒力调节因子。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
EVGENY A NUDLER其他文献
EVGENY A NUDLER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('EVGENY A NUDLER', 18)}}的其他基金
Transcription termination and gene regulation by Rho: Integrative analysis
Rho 的转录终止和基因调控:整合分析
- 批准号:
10152645 - 财政年份:2018
- 资助金额:
$ 21.13万 - 项目类别:
Role of RNA polymerase in DNA stability and repair
RNA 聚合酶在 DNA 稳定性和修复中的作用
- 批准号:
9115198 - 财政年份:2014
- 资助金额:
$ 21.13万 - 项目类别:
Transcription termination and its regulation in E. Coli
大肠杆菌中的转录终止及其调控
- 批准号:
8672454 - 财政年份:2014
- 资助金额:
$ 21.13万 - 项目类别:
Role of RNA polymerase in DNA stability and repair
RNA 聚合酶在 DNA 稳定性和修复中的作用
- 批准号:
8914643 - 财政年份:2014
- 资助金额:
$ 21.13万 - 项目类别:
Role of RNA polymerase in DNA stability and repair
RNA 聚合酶在 DNA 稳定性和修复中的作用
- 批准号:
8760509 - 财政年份:2014
- 资助金额:
$ 21.13万 - 项目类别:
Proteomics of RNA polymerase interactomes in pathogenic bacteria
病原菌 RNA 聚合酶相互作用组的蛋白质组学
- 批准号:
8173472 - 财政年份:2011
- 资助金额:
$ 21.13万 - 项目类别:
Mechanisms of Anthrax Virulence Factor AtxA.
炭疽毒力因子 AtxA 的机制。
- 批准号:
8204682 - 财政年份:2010
- 资助金额:
$ 21.13万 - 项目类别:
相似国自然基金
Mpro蛋白靶向亲和层析定向挖掘白及属中药抗新冠肺炎活性芪类成分
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
原子水平一体化构建腺相关病毒亲和层析介质及分子设计基础
- 批准号:
- 批准年份:2020
- 资助金额:63 万元
- 项目类别:面上项目
基于凝集素芯片与凝集素亲和层析技术的参芪扶正注射液联合 IFN-α对肝癌切除术后复发转移干预机制的糖蛋白组学研究
- 批准号:81803954
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
基于生物质谱和亲和层析策略的大肠杆菌O157: H7特异性抗体的靶蛋白及多肽抗原表位的鉴定与研究
- 批准号:31701680
- 批准年份:2017
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
治疗SLE复方中的抗炎物质分离及对狼疮活动干预机制的研究
- 批准号:81673857
- 批准年份:2016
- 资助金额:55.0 万元
- 项目类别:面上项目
相似海外基金
Systematic Phenotypic Analysis of the Gram-positive Envelope
革兰氏阳性包膜的系统表型分析
- 批准号:
8594970 - 财政年份:2013
- 资助金额:
$ 21.13万 - 项目类别:
Proteomics of RNA polymerase interactomes in pathogenic bacteria
病原菌 RNA 聚合酶相互作用组的蛋白质组学
- 批准号:
8173472 - 财政年份:2011
- 资助金额:
$ 21.13万 - 项目类别:
Receptor disulfide allosteric regulation of anthrax toxin action
炭疽毒素作用的受体二硫键变构调节
- 批准号:
8255487 - 财政年份:2011
- 资助金额:
$ 21.13万 - 项目类别:
cGMP manufacturing of PBI-220, a broad spectrum immunoadhesin therapeutic against
PBI-220 的 cGMP 生产,一种广谱免疫粘附素治疗药物
- 批准号:
8262149 - 财政年份:2011
- 资助金额:
$ 21.13万 - 项目类别: